sepsis – Medxy AI

Evaluating the Impact of Early Mobilization in Mechanically Ventilated ICU Patients with Sepsis or Acute Respiratory Failure: Insights from the EVER Multicenter RCT

By MedXY 09/01/2026

The EVER trial examined if a structured early mobilization protocol improves functional outcomes in ventilated patients with sepsis or respiratory failure. Despite earlier and increased mobilization, no significant functional benefit was observed at ICU discharge or 12 months.

Critical Care news Plastic Surgery

Impact of Early Surgical Excision on Survival in Severe Burns: Insights from a Multicenter Prospective Study

By MedXY 08/18/2026

Early surgical excision within 48 hours significantly lowers 90-day mortality in adults with severe burns, suggesting it as a beneficial strategy despite increased sepsis risk.

Clinical Updates news

Incidence, Outcomes, and Risk Factors for Mortality in Patients With Sepsis in South Korea: Insights From a Nationwide Cohort Study and Related Evidence

By MedXY 08/17/2026

This review synthesizes nationwide epidemiological trends of sepsis in South Korea from 2011 to 2022, elucidating incidence increases, declining in-hospital mortality, and key clinical and socioeconomic mortality determinants alongside relevant complementary studies.

Critical Care news OB/GYN & Women’s Health

Impact of Texas Abortion Ban on Critical Illness in Hospitalized Pregnant Women: A Retrospective Cohort Analysis

By MedXY 08/10/2026

The Texas Senate Bill 8 abortion ban is linked to an increased rate of critical illness, sepsis, and infections among hospitalized pregnant women with high-risk features, highlighting significant implications for maternal healthcare in restrictive states.

Critical Care Nephrology news

H3.1 Nucleosomes as Predictive Biomarkers for Renal Replacement Therapy and Mortality in Sepsis: Insights from the SISPCT Trial

By MedXY 08/07/2026

Elevated plasma levels of H3.1 nucleosomes at ICU admission correlate with increased mortality and acute kidney injury requiring renal replacement therapy in sepsis, highlighting their potential as prognostic biomarkers.

Critical Care Infectious Diseases news

Early Shenfu Injection in Sepsis: Impact on Hemodynamics, Mortality, and Microcirculation in a Multicenter RCT

By MedXY 07/17/2026

Early administration of Shenfu injection in septic ICU patients did not reduce vasopressor use but was associated with lower mortality and improved microcirculation, warranting further validation.

Critical Care Infectious Diseases news

Harnessing Precision Medicine: The APS Consortium’s National Platform for Phenotyping ARDS, Pneumonia, and Sepsis

By MedXY 07/15/2026

The APS Consortium establishes a large, prospective cohort of critically ill adults with ARDS, pneumonia, and sepsis to enable biologically based phenotyping, leveraging rich clinical data and biospecimens for improved understanding and therapeutic development.

Cardiology Critical Care news

Identifying Cardiovascular Subphenotypes in Sepsis: Toward Personalized Hemodynamic Management

By MedXY 07/07/2026

Unsupervised clustering of echocardiographic and hemodynamic data in sepsis reveals four distinct cardiovascular subphenotypes, each with unique mortality risks and responses to treatment, enabling personalized shock management strategies.

Critical Care Internal Medicine news

Comparing Early Restrictive and Liberal Fluid Strategies in Sepsis-Induced Hypotension: Long-Term Effects on Patient-Centered Outcomes

By MedXY 07/05/2026

A randomized trial showed no significant differences in 6- and 12-month cognitive, physical, and quality of life outcomes between early restrictive and liberal fluid resuscitation in sepsis-induced hypotension.

Critical Care Infectious Diseases news

Clinical Metagenomics in Sepsis: Insights from the DigiSep Randomized Controlled Trial

By MedXY 07/02/2026

The DigiSep trial assessed the impact of metagenomic next-generation sequencing (mNGS) on sepsis outcomes. While primary endpoint improvement was not significant, secondary analyses revealed benefits in mechanical ventilation duration, shock resolution, and quality of life without raising healthcare costs.

Critical Care Infectious Diseases news

Impact of Appropriate Antimicrobial Therapy on ICU Patient Outcomes: Subanalysis of the DIANA Study Dataset

By MedXY 06/05/2026

In critically ill ICU patients with confirmed bacterial infections, appropriate empiric antimicrobial therapy was common and independently linked to lower 28-day mortality and more antimicrobial-free days.

Critical Care Infectious Diseases news

Biomarker Signatures in Sepsis: Linking Host Response to Clinical Outcomes

By MedXY 04/28/2026

A prospective cohort study identifies biomarker signatures for host resistance, disease tolerance, and damage in sepsis, revealing associations with mortality and sepsis subtypes.

Critical Care Infectious Diseases news

Cultural Diversity in ICU: A Protective Factor Against Sepsis Mortality

By MedXY 04/24/2026

A multicenter study reveals that culturally and linguistically diverse patients with sepsis had lower in-hospital mortality and shorter ICU stays compared to non-CaLD patients, challenging prior assumptions about healthcare disparities.

Critical Care Emergency Medicine news

Rethinking Shock Management: From Standardized Protocols to Personalized Precision Medicine

By MedXY 03/19/2026

Expert consensus highlights a shift in shock treatment, emphasizing that standardized protocols must give way to personalized, physiology-driven bedside care to prevent iatrogenic injury and improve survival.

Critical Care Diabetes & Endocrinology news

Precision Prognostics in Sepsis: How Stress Hyperglycemia and Glucose Variability Define Mortality Risk Across Metabolic Profiles

By MedXY 02/04/2026

This study reveals that combining stress hyperglycemia ratio and glucose variability significantly improves mortality prediction in sepsis, with risk patterns varying significantly based on a patient's baseline metabolic status (Normal, Pre-DM, or DM).

Critical Care Emergency Medicine news

Sepsis Subtypes Are Fluid: How ‘Fuzzy’ Classification Explains Treatment Variability and Patient Trajectories

By MedXY 01/26/2026

A large-scale study of 35,691 sepsis patients reveals that clinical subtypes are highly dynamic, with 82% of patients changing categories within 48 hours. This classification uncertainty significantly impacts treatment response and long-term mortality outcomes.

Critical Care Infectious Diseases news

Hemodynamic vs. Neurological Phenotypes in Adult Invasive Meningococcal Disease: Insights from the Nationwide RETRO-MENINGO Study

By MedXY 12/28/2025

The RETRO-MENINGO study of 654 adults reveals that hemodynamic presentations of invasive meningococcal disease carry a five-fold higher mortality risk than neurological forms. Early parenteral antibiotic administration remains the most critical modifiable factor for patient survival.

Critical Care Gastroenterology news

Tracking the Immune Pulse: Why mHLA-DR Trajectories Predict Survival in Sepsis and Liver Transplantation

By MedXY 12/27/2025

Large-scale cohort and prospective data reveal that monocyte HLA-DR expression is a dynamic predictor of ICU-acquired infections and mortality, offering a roadmap for personalized immunostimulant therapy in septic shock and transplant patients.

Critical Care Infectious Diseases news

Sepsis Survival in Australia and New Zealand: Analyzing Two Decades of Progress and the Recent Mortality Rebound

By MedXY 12/27/2025

A large-scale study of over 300,000 ANZ ICU patients reveals that sepsis mortality plummeted from 28% to 11% between 2000 and 2020, followed by a concerning 0.9% annual increase through 2023, highlighting both clinical triumphs and emerging challenges in critical care.

Critical Care Infectious Diseases news

Safe Stewardship: Antibiotic De-escalation by Day 4 Reduces Hospitalization Length Without Increasing Mortality in Community-Onset Sepsis

By MedXY 12/24/2025

A large-scale target trial emulation demonstrates that de-escalating anti-MRSA and anti-pseudomonal therapy on day 4 of sepsis treatment is safe, associated with fewer antibiotic days, and leads to shorter hospital stays compared to continuing broad-spectrum regimens.